Login / Signup
Pallavur Sivakumar
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Monoclonal Antibody
Emergency Department
Cell Surface
Nk Cells
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Henry Chan
,
Christina V Trout
,
David Mikolon
,
Preston Adams
,
Roberto Guzman
,
Konstantinos Mavrommatis
,
Mahan Abbasian
,
Haralambos Hadjivassiliou
,
Lawrence Dearth
,
Brian A Fox
,
Pallavur Sivakumar
,
Ho Cho
,
Kandasamy Hariharan
Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies.
Cancer research communications
4 (2) (2024)
Henry Chan
,
Christina V Trout
,
David Mikolon
,
Preston Adams
,
Roberto Guzman
,
Konstantinos Mavrommatis
,
Mahan Abbasian
,
Haralambos Hadjivassiliou
,
Lawrence Dearth
,
Brian A Fox
,
Pallavur Sivakumar
,
Ho Cho
,
Kandasamy Hariharan
Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies.
Cancer research communications
4 (2) (2024)
Henry Chan
,
Christina V Trout
,
David Mikolon
,
Preston Adams
,
Roberto Guzman
,
Konstantinos Mavrommatis
,
Mahan Abbasian
,
Haralambos Hadjivassiliou
,
Lawrence Dearth
,
Brian A Fox
,
Pallavur Sivakumar
,
Ho Cho
,
Kandasamy Hariharan
Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies.
Cancer research communications
4 (2) (2024)
Henry Chan
,
Christina V Trout
,
David Mikolon
,
Preston Adams
,
Roberto Guzman
,
Konstantinos Mavrommatis
,
Mahan Abbasian
,
Haralambos Hadjivassiliou
,
Lawrence Dearth
,
Brian A Fox
,
Pallavur Sivakumar
,
Ho Cho
,
Kandasamy Hariharan
Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα that Enhances Macrophage-Mediated Tumor Phagocytosis when Combined with Opsonizing Antibodies.
Cancer research communications
(2024)